Market Cap 206.88M
Revenue (ttm) 0.00
Net Income (ttm) -78.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,003,800
Avg Vol 434,772
Day's Range N/A - N/A
Shares Out 18.67M
Stochastic %K 1%
Beta 2.63
Analysts Strong Sell
Price Target $35.89

Company Profile

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

Industry: Biotechnology
Sector: Healthcare
Phone: 617 963 0100
Address:
500 River Ridge Drive, Norwood, United States
RandomUser1001
RandomUser1001 Sep. 9 at 8:11 PM
$CRBP Last traded at .08 💀
1 · Reply
h8ster
h8ster Sep. 9 at 8:09 PM
$CRBP Solid -16% down day in anticipation of Phase 1B readouts in the coming days. Smart profit taking by those that have experience playing this company. Odds overwhelmingly point to a huge sell off regardless of the results. Only above expected results will see a day of green. With any luck, bad retail investors get wiped out, as they always do here, and this can go back to the $7 loading range. Remember. Bad readouts mean 50% drop or more. Good/expected readout results in a sell the news event, dropping it 20%-30%. Only an above expected readout will result in the ticker going green and it will be a big one. Odds point to a good/expected readout. Real traders sold in the $10' & $11's, locked in profits and are ready to buy the panic dip. Amatuers will sell for losses in the low $9's-$8's $7's then chase it high in the $10's. Amazing how history always repeats itself.
0 · Reply
shlomiko
shlomiko Sep. 9 at 7:25 PM
$CRBP — Fear is high, and that’s exactly when opportunity shows up. CRB-913 doesn’t need to be perfect — it needs to show meaningful weight loss with a clean safety profile. If CANYON-1 confirms what we saw in Phase 1a, the market may have seriously underestimated this asset. Big catalyst. Big risk. Potentially much bigger reward. I’m buying the fear, not chasing the news. 🚀
0 · Reply
h8ster
h8ster Sep. 9 at 6:16 PM
$CRBP For those that have been here a while, remember what happened to CRBP when Novo's phase 2's failed. Similar drug, but different molecule than CRBP's 913. There is going to be a ton of 'risk repositioning' leading up to these phase 1B results. It will be catastrophic if the readouts disappoint. Even if readouts are good, we could see yet another a huge 'sell the news' reaction. So, the current repositioning is totally normal given the risk assessment. there are just 3 things that can happen after the readouts. Complete collapse of 50% or more on failure or flat results, 20%-30% drop on a sell the news reaction if everything is fine and meet expectations. Or a 80%-100% surge, on greater than expected readouts. So, odds have this collapsing after readouts regardless, unless we get super great results. Thats why we are dropping. We are almost guaranteed a big sell off. Classic preemptive profit taking before a huge catalyst.
0 · Reply
Davy_Stockett
Davy_Stockett Sep. 9 at 6:10 PM
$CRBP looks like it might be a good time to buy.
0 · Reply
Darling69
Darling69 Sep. 9 at 6:05 PM
$CRBP What the hell is happening?
0 · Reply
shahid7777
shahid7777 Sep. 9 at 6:01 PM
$CRBP Yearly or Twice yearly dosing https://www.businesswire.com/news/home/20260908497250/en/Moonwalk-Biosciences-Announces-%2470-Million-Series-B-Financing-to-Advance-Adipose-Targeted-RNAi-Therapies-for-Obesity-and-Cardiometabolic-Diseases
0 · Reply
birdmine
birdmine Sep. 9 at 5:51 PM
$CRBP fuck!!! This trash won’t even get to the teens at this point!!!
0 · Reply
h8ster
h8ster Sep. 9 at 5:24 PM
$CRBP Good flush out. Really hoping it sparks some retail panic selling. Volume is low, so there definitely isn't a leak of anything. With a O/S of just 19M, it doesn't take much for this to have violence one day drops as it has done in the past. This is a classic repositioning of funds as oil rises, inflation risk increases, etc, etc. I will patiently wait for the $8's. I mean, who on earth actually sells on these flush outs? Or even any red day for that matter.
0 · Reply
judgeyoung2
judgeyoung2 Sep. 9 at 4:28 PM
$CRBP historically they drop news on Thursdays and Tuesdays
0 · Reply
Latest News on CRBP
Corbus Pharmaceuticals Holdings Earnings release: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 4 weeks ago

Corbus Pharmaceuticals Holdings Earnings release: Q2 2026


Corbus Pharmaceuticals Holdings Quarterly report: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 4 weeks ago

Corbus Pharmaceuticals Holdings Quarterly report: Q2 2026


Corbus Pharmaceuticals Holdings Slides: FY 2026

Jun 4, 2026, 4:55 PM EDT - 3 months ago

Corbus Pharmaceuticals Holdings Slides: FY 2026


Corbus Pharmaceuticals Holdings Transcript: KOL event

Jun 1, 2026, 7:30 AM EDT - 3 months ago

Corbus Pharmaceuticals Holdings Transcript: KOL event


Corbus Pharmaceuticals share selloff overdone, says Guggenheim

2026-05-26T16:58:14.000Z - 3 months ago

Corbus Pharmaceuticals share selloff overdone, says Guggenheim


Corbus Pharmaceuticals Holdings Transcript: Study update

May 26, 2026, 8:00 AM EDT - 3 months ago

Corbus Pharmaceuticals Holdings Transcript: Study update


Corbus Pharmaceuticals Holdings Press release: Study update

May 26, 2026, 8:00 AM EDT - 3 months ago

Corbus Pharmaceuticals Holdings Press release: Study update


Corbus Pharmaceuticals Holdings Slides: Study update

May 26, 2026, 8:00 AM EDT - 3 months ago

Corbus Pharmaceuticals Holdings Slides: Study update


Corbus Pharmaceuticals reports updated CRB-701 Phase 1/2 data

2026-05-26T11:51:41.000Z - 3 months ago

Corbus Pharmaceuticals reports updated CRB-701 Phase 1/2 data


Corbus Pharmaceuticals Holdings Slides: Corporate presentation

May 26, 2026, 7:00 AM EDT - 3 months ago

Corbus Pharmaceuticals Holdings Slides: Corporate presentation


Corbus Pharmaceuticals Holdings Slides: Corporate presentation

May 14, 2026, 7:00 AM EDT - 3 months ago

Corbus Pharmaceuticals Holdings Slides: Corporate presentation


Corbus Pharmaceuticals Holdings Transcript: AGM 2026

May 13, 2026, 9:00 AM EDT - 3 months ago

Corbus Pharmaceuticals Holdings Transcript: AGM 2026


Corbus Pharmaceuticals Holdings Earnings release: Q1 2026

May 12, 2026, 8:00 AM EDT - 4 months ago

Corbus Pharmaceuticals Holdings Earnings release: Q1 2026


Corbus Pharmaceuticals Holdings Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 4 months ago

Corbus Pharmaceuticals Holdings Quarterly report: Q1 2026


Corbus Pharmaceuticals initiated with a Buy at Guggenheim

2026-04-29T09:21:07.000Z - 4 months ago

Corbus Pharmaceuticals initiated with a Buy at Guggenheim


Corbus Pharmaceuticals initiated with a Buy at Guggenheim

2026-04-28T20:17:12.000Z - 4 months ago

Corbus Pharmaceuticals initiated with a Buy at Guggenheim


Corbus Pharmaceuticals Holdings Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Corbus Pharmaceuticals Holdings Proxy statement: Proxy filing


Corbus Pharmaceuticals Holdings Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 5 months ago

Corbus Pharmaceuticals Holdings Proxy statement: Proxy filing


Corbus Pharmaceuticals Holdings Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 5 months ago

Corbus Pharmaceuticals Holdings Proxy statement: Proxy filing


Corbus Pharmaceuticals Holdings Slides: Corporate presentation

Mar 16, 2026, 7:00 AM EDT - 5 months ago

Corbus Pharmaceuticals Holdings Slides: Corporate presentation


Corbus Pharmaceuticals Holdings Annual report: Q4 2025

Mar 9, 2026, 7:30 AM EDT - 6 months ago

Corbus Pharmaceuticals Holdings Annual report: Q4 2025


Corbus Pharmaceuticals Holdings Earnings release: Q4 2025

Mar 9, 2026, 7:30 AM EDT - 6 months ago

Corbus Pharmaceuticals Holdings Earnings release: Q4 2025


Corbus Pharmaceuticals Holdings Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 6 months ago

Corbus Pharmaceuticals Holdings Slides: Corporate presentation


Corbus Pharmaceuticals Holdings Slides: Corporate presentation

Feb 25, 2026, 7:00 AM EST - 6 months ago

Corbus Pharmaceuticals Holdings Slides: Corporate presentation


Corbus Pharmaceuticals Holdings Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 8 months ago

Corbus Pharmaceuticals Holdings Slides: Corporate presentation


Corbus Pharmaceuticals Holdings Transcript: Study Update

Dec 11, 2025, 8:00 AM EST - 9 months ago

Corbus Pharmaceuticals Holdings Transcript: Study Update


Corbus Pharmaceuticals Holdings Press release: Study Update

Dec 11, 2025, 8:00 AM EST - 9 months ago

Corbus Pharmaceuticals Holdings Press release: Study Update


Corbus Pharmaceuticals Holdings Slides: Corporate Presentation

Dec 11, 2025, 7:00 AM EST - 9 months ago

Corbus Pharmaceuticals Holdings Slides: Corporate Presentation


Corbus Pharmaceuticals Holdings Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 10 months ago

Corbus Pharmaceuticals Holdings Quarterly report: Q3 2025


Corbus Pharmaceuticals Holdings Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 10 months ago

Corbus Pharmaceuticals Holdings Earnings release: Q3 2025


Corbus Pharmaceuticals Announces Pricing of Public Offering

Oct 31, 2025, 2:40 AM EDT - 10 months ago

Corbus Pharmaceuticals Announces Pricing of Public Offering


Corbus Pharmaceuticals Announces Proposed Public Offering

Oct 30, 2025, 4:31 PM EDT - 10 months ago

Corbus Pharmaceuticals Announces Proposed Public Offering


Corbus Pharmaceuticals Holdings Slides: Corporate Presentation

Oct 19, 2025, 7:00 AM EDT - 10 months ago

Corbus Pharmaceuticals Holdings Slides: Corporate Presentation


Corbus Pharmaceuticals Holdings Transcript: KOL Event

Oct 19, 2025, 4:00 AM EDT - 10 months ago

Corbus Pharmaceuticals Holdings Transcript: KOL Event


Corbus Pharmaceuticals Holdings Press release: KOL Event

Oct 19, 2025, 4:00 AM EDT - 10 months ago

Corbus Pharmaceuticals Holdings Press release: KOL Event


Corbus Pharmaceuticals Holdings Slides: KOL Event

Oct 19, 2025, 4:00 AM EDT - 10 months ago

Corbus Pharmaceuticals Holdings Slides: KOL Event


Corbus Pharmaceuticals Holdings Quarterly report: Q2 2025

Aug 5, 2025, 9:00 AM EDT - 1 year ago

Corbus Pharmaceuticals Holdings Quarterly report: Q2 2025


Corbus Pharmaceuticals Holdings Earnings release: Q2 2025

Aug 5, 2025, 9:00 AM EDT - 1 year ago

Corbus Pharmaceuticals Holdings Earnings release: Q2 2025


Corbus Pharmaceuticals Holdings Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Corbus Pharmaceuticals Holdings Quarterly report: Q1 2025


Corbus Pharmaceuticals Holdings Earnings release: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Corbus Pharmaceuticals Holdings Earnings release: Q1 2025


Corbus Pharmaceuticals Holdings Annual report: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Corbus Pharmaceuticals Holdings Annual report: Q4 2024


Corbus Pharmaceuticals Holdings Earnings release: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Corbus Pharmaceuticals Holdings Earnings release: Q4 2024


Corbus Pharmaceuticals Holdings Quarterly report: Q3 2024

Nov 7, 2024, 9:00 AM EST - 1 year ago

Corbus Pharmaceuticals Holdings Quarterly report: Q3 2024


Corbus Pharmaceuticals Holdings Earnings release: Q3 2024

Nov 7, 2024, 9:00 AM EST - 1 year ago

Corbus Pharmaceuticals Holdings Earnings release: Q3 2024


Corbus Pharmaceuticals Holdings Quarterly report: Q2 2024

Aug 6, 2024, 8:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Quarterly report: Q2 2024


Corbus Pharmaceuticals Holdings Earnings release: Q2 2024

Aug 6, 2024, 8:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Earnings release: Q2 2024


Corbus Pharmaceuticals Holdings Quarterly report: Q1 2024

May 7, 2024, 7:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Quarterly report: Q1 2024


Corbus Pharmaceuticals Holdings Earnings release: Q1 2024

May 7, 2024, 7:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Earnings release: Q1 2024


Corbus Pharmaceuticals Holdings Proxy statement: Proxy Filing

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Proxy statement: Proxy Filing


Corbus Pharmaceuticals Holdings Proxy statement: Proxy Filing

Apr 2, 2024, 8:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Proxy statement: Proxy Filing


Corbus Pharmaceuticals Holdings Proxy statement: Proxy Filing

Apr 2, 2024, 8:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Proxy statement: Proxy Filing


Corbus Pharmaceuticals Holdings Proxy statement: Proxy Filing

Mar 22, 2024, 8:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Proxy statement: Proxy Filing


Corbus Pharmaceuticals Holdings Earnings release: Q4 2023

Mar 12, 2024, 8:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Earnings release: Q4 2023


Corbus Pharmaceuticals Holdings Annual report: Q4 2023

Mar 12, 2024, 8:00 AM EDT - 2 years ago

Corbus Pharmaceuticals Holdings Annual report: Q4 2023


RandomUser1001
RandomUser1001 Sep. 9 at 8:11 PM
$CRBP Last traded at .08 💀
1 · Reply
h8ster
h8ster Sep. 9 at 8:09 PM
$CRBP Solid -16% down day in anticipation of Phase 1B readouts in the coming days. Smart profit taking by those that have experience playing this company. Odds overwhelmingly point to a huge sell off regardless of the results. Only above expected results will see a day of green. With any luck, bad retail investors get wiped out, as they always do here, and this can go back to the $7 loading range. Remember. Bad readouts mean 50% drop or more. Good/expected readout results in a sell the news event, dropping it 20%-30%. Only an above expected readout will result in the ticker going green and it will be a big one. Odds point to a good/expected readout. Real traders sold in the $10' & $11's, locked in profits and are ready to buy the panic dip. Amatuers will sell for losses in the low $9's-$8's $7's then chase it high in the $10's. Amazing how history always repeats itself.
0 · Reply
shlomiko
shlomiko Sep. 9 at 7:25 PM
$CRBP — Fear is high, and that’s exactly when opportunity shows up. CRB-913 doesn’t need to be perfect — it needs to show meaningful weight loss with a clean safety profile. If CANYON-1 confirms what we saw in Phase 1a, the market may have seriously underestimated this asset. Big catalyst. Big risk. Potentially much bigger reward. I’m buying the fear, not chasing the news. 🚀
0 · Reply
h8ster
h8ster Sep. 9 at 6:16 PM
$CRBP For those that have been here a while, remember what happened to CRBP when Novo's phase 2's failed. Similar drug, but different molecule than CRBP's 913. There is going to be a ton of 'risk repositioning' leading up to these phase 1B results. It will be catastrophic if the readouts disappoint. Even if readouts are good, we could see yet another a huge 'sell the news' reaction. So, the current repositioning is totally normal given the risk assessment. there are just 3 things that can happen after the readouts. Complete collapse of 50% or more on failure or flat results, 20%-30% drop on a sell the news reaction if everything is fine and meet expectations. Or a 80%-100% surge, on greater than expected readouts. So, odds have this collapsing after readouts regardless, unless we get super great results. Thats why we are dropping. We are almost guaranteed a big sell off. Classic preemptive profit taking before a huge catalyst.
0 · Reply
Davy_Stockett
Davy_Stockett Sep. 9 at 6:10 PM
$CRBP looks like it might be a good time to buy.
0 · Reply
Darling69
Darling69 Sep. 9 at 6:05 PM
$CRBP What the hell is happening?
0 · Reply
shahid7777
shahid7777 Sep. 9 at 6:01 PM
$CRBP Yearly or Twice yearly dosing https://www.businesswire.com/news/home/20260908497250/en/Moonwalk-Biosciences-Announces-%2470-Million-Series-B-Financing-to-Advance-Adipose-Targeted-RNAi-Therapies-for-Obesity-and-Cardiometabolic-Diseases
0 · Reply
birdmine
birdmine Sep. 9 at 5:51 PM
$CRBP fuck!!! This trash won’t even get to the teens at this point!!!
0 · Reply
h8ster
h8ster Sep. 9 at 5:24 PM
$CRBP Good flush out. Really hoping it sparks some retail panic selling. Volume is low, so there definitely isn't a leak of anything. With a O/S of just 19M, it doesn't take much for this to have violence one day drops as it has done in the past. This is a classic repositioning of funds as oil rises, inflation risk increases, etc, etc. I will patiently wait for the $8's. I mean, who on earth actually sells on these flush outs? Or even any red day for that matter.
0 · Reply
judgeyoung2
judgeyoung2 Sep. 9 at 4:28 PM
$CRBP historically they drop news on Thursdays and Tuesdays
0 · Reply
shlomiko
shlomiko Sep. 9 at 3:55 PM
$CRBP time to add….
0 · Reply
judgeyoung2
judgeyoung2 Sep. 9 at 2:51 PM
$CRBP wow
0 · Reply
birdmine
birdmine Sep. 9 at 1:41 PM
$CRBP sigh!! This trash is back at it. I hope history repeats itself and October is fantastic.
0 · Reply
shlomiko
shlomiko Sep. 8 at 5:29 PM
0 · Reply
marley401
marley401 Sep. 4 at 8:00 PM
$CRBP Sep18 15c @ .40 🏁
2 · Reply
SannieVerraderlijk
SannieVerraderlijk Sep. 4 at 4:49 PM
$CRBP And i'm out, won't fight the obvious here, good luck to the gamblers, may you bathe in riches
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Sep. 1 at 10:13 PM
$TENX big buys yet no price movement, tutes loading looks like, options getting accumulated as well, rerate is coming, similar thing happened at $CRBP today on the 22.5 Dec calls....
2 · Reply
negligiblecat
negligiblecat Sep. 1 at 3:48 PM
$CRBP Could be anywhere from mid Sep to early Oct
2 · Reply
shlomiko
shlomiko Aug. 28 at 12:29 PM
0 · Reply
RandomInvestor777
RandomInvestor777 Aug. 27 at 10:01 PM
$CRBP there's no date, its likely early to mid September. Most likely a fail but good pos for a success (success here is clean safety and more than 3 WL)
1 · Reply
Billyraybob
Billyraybob Aug. 27 at 4:31 PM
$CRBP when is data being released in Sept? Did they announce a date? I keep looking for a announcement date but no luck
0 · Reply
ddxrich
ddxrich Aug. 26 at 9:51 PM
$CRBP Next stop $12
0 · Reply